JCRB0251 SCH
Cell information
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB0251 | Cell Name | SCH |
|---|---|---|---|
| Profile | choriocarcinoma arising at stomach from male patient | Other Name | SCH |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | Age | ||
| Identity | available | Tissue for Primary Cancer | stomach |
| Case history | Metastasis | ||
| Tissue Metastasized | Genetics | stomach, choriocarcinoma, 46 year-old male | |
| Life Span | Crisis PDL | ||
| Morphology | Character | stomach, choriocarcinoma, 46 year-old male | |
| Classify | Established by | Ohboshi,S. | |
| Registered by | Regulation for Distribution | ||
| Comment | Mycoplasmas eliminated by MC-210 in FDSC. | Year | 1989 |
| Medium | RPMI1640 medium with 10% fetal calf serum | Methods for Passages | Cells are treated with 0.25 % trypsin and 0.02 % EDTA. |
| Cell Number on Passage | split ratio=1/10 | Race | |
| CO2 Conc. | 5 % | Tissue Sampling | stomach |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:3095279 | Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel. Nakatani H,Tahara E,Yoshida T,Sakamoto H,Suzuki T,Watanabe H,Sekiguchi M,Kaneko Y,Sakurai M,Terada M Jpn J Cancer Res. 1986 Sep;77(9):849-53 |
| Pubmed id:1170940 | A human gastric choriocarcinoma cell line with human chorionic gonadotropin and placental alkaline phosphatase production. Kameya T,Kuramoto H,Suzuki K,Kenjo T,Oshikiri T,Hayashi H,Itakura M Cancer Res. 1975 Aug;35(8):2025-32 |
| Pubmed id:5058640 | Use of 1-nitroso-2-naphthol in quantitative determination of medicinal phenolic compounds. Bhansali KG J Pharm Sci. 1972 Jan;61(1):146-7 |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
| Movies |
|---|
|
|
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB0251 | Cell Name | |
|---|---|---|---|
| LOT No. | 07022010 | Lot Specification | distribution |
| Medium | RPMI1640 medium with 10% fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
| Cell Density at Seeding | 1.3 - 1.7 x 10^5 cells/mL | Methods for Passages | 0.25% trypsin and 0.02% EDTA. Passage twice a week. |
| Doubling Time | approx. 1.5 days. | Cell Number in Vial (cells/1ml) | 2.5 x 10^6 |
| Viability at cell freezing (%) | 93.5 | Antibiotics Used | free |
| Passage Number | P21 | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0251 | Cell Name | |
|---|---|---|---|
| LOT No. | 102594 | Lot Specification | distribution |
| Medium | RPMI1640 + FCS 10 % | Temperature | 37 |
| Cell Density at Seeding | Methods for Passages | 0.02 % EDTA and 0.25 % trypsin | |
| Doubling Time | Cell Number in Vial (cells/1ml) | ||
| Viability at cell freezing (%) | Antibiotics Used | ||
| Passage Number | PDL | ||
| Sterility: MYCOPLASMA | Sterility: BACTERIA | ||
| Sterility: FUNGI | Isozyme Analysis | ||
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Exoteric Gene | ||
| Medium for Freezing | CO2 Conc. | ||
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0251 | Cell Name | SCH |
|---|---|---|---|
| LOT No. | 04192019 | Lot Specification | distribution |
| Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
| Cell Density at Seeding | 0.5 - 1.7 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
| Doubling Time | approx. 28 hrs. | Cell Number in Vial (cells/1ml) | 1.9 x 10^6 |
| Viability at cell freezing (%) | 79.0 | Antibiotics Used | free |
| Passage Number | P21 | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 80.1 | Additional information |
| Cell No. | JCRB0251 | Cell Name | SCH |
|---|---|---|---|
| LOT No. | 10162023 | Lot Specification | distribution |
| Medium | RPMI1640(GIBCO Cat#11875) with 10% heat inactivated fetal bovine serum (SIGMA, Cat#172012, Lot#12J396) | Temperature | 37 C |
| Cell Density at Seeding | 0.833-1.12x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.88x10^6 |
| Viability at cell freezing (%) | 87.66 | Antibiotics Used | free |
| Passage Number | p21 | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:11 D13S317:11,12 D7S820:10,11 D16S539:9 VWA:17 TH01:6,7 AM:X,Y TPOX:11 CSF1PO:10,11 |
| Adhesion | Yes | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER (LYMPHOTEC Inc., CS-02-001, NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 87.24 | Additional information |
| Images |
|---|
|
|








